{"id":"W4206710181","doi":"10.1016/j.euo.2021.12.007","title":"Pembrolizumab outperforms tyrosine kinase inhibitors as adjuvant treatment in patients with high-risk renal cell carcinoma after nephrectomy","year":2022,"lang":"en","type":"article","venue":"European Urology Oncology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Medicine; Pembrolizumab; Pazopanib; Internal medicine; Renal cell carcinoma; Hazard ratio; Kidney cancer; Adverse effect; Oncology; Placebo; Nephrectomy; Adjuvant; Confidence interval; Cancer; Kidney; Sunitinib; Immunotherapy; Pathology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0003697825,0.0005703206,0.000910072,0.0005274318,0.0002307915,0.0000115508,0.0002160767,0.0001248331,0.001095179],"category_scores_gemma":[0.00003036375,0.0004200207,0.0001794051,0.0003748871,0.0002594513,0.00007119004,0.0003439611,0.0008394301,0.0004036636],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00188789,"about_ca_system_score_gemma":0.0004582423,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0007110327,"about_ca_topic_score_gemma":0.0001663301,"domain_scores_codex":[0.9955536,0.001494236,0.000676782,0.0009898311,0.0004280561,0.0008575519],"domain_scores_gemma":[0.9983273,0.0001318267,0.0003463622,0.000748499,0.00009513024,0.0003508912],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.0273814,0.004583236,0.9379237,0.00001860893,0.000129924,0.01576284,0.001264021,0.000307622,0.0002615854,0.00001217562,0.0005633095,0.01179164],"study_design_scores_gemma":[0.03384357,0.07307155,0.8602087,0.000005627336,0.0005124826,0.0003837405,0.00009538292,0.00001891433,0.0008963844,0.00001224059,0.03061852,0.0003328742],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9861163,0.0008470181,0.000002917793,0.0006017821,0.0004607175,0.001442075,0.00007228114,0.00008803587,0.01036882],"genre_scores_gemma":[0.9957916,0.00002626404,0.0003100328,0.001310206,0.000233157,0.0003889118,0.000373491,0.000144649,0.001421747],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.07771494,"threshold_uncertainty_score":0.9998252,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.006648434148015535,"score_gpt":0.2094829070434465,"score_spread":0.2028344728954309,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}